Discontinued — last reported Q4 '16
Non-Current Assets
Total investments
Royalty Pharma Total investments increased by 1.1% to $173.27M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 22.8%, from $141.08M to $173.27M. Over 5 years (FY 2020 to FY 2025), Total investments shows a downward trend with a -10.5% CAGR.
Analysis
StatementBalance Sheet Statement
SectionNon-Current Assets
CategoryCapital Allocation
SignalContext dependent
VolatilityModerate
First reportedQ4 2014
Last reportedQ4 2016
How to read this metric
Growth in total investments often reflects the deployment of excess liquidity, while a decline may signal asset liquidation to fund loan growth or meet liquidity needs.
Detailed definition
The aggregate book value of all investment assets held by the bank, including debt securities, equity securities, and ot...
Peer comparison
A core metric for all banks; peers typically report this as part of the investment securities portfolio.
Metric ID:
fin_total_investmentsHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $184.04M | $264.77M | $269.80M | $267.64M | $304.45M | $262.82M | $112.35M | $101.53M | $142.80M | $144.34M | $199.49M | $277.22M | $178.02M | $228.87M | $186.96M | $141.08M | $110.53M | $129.39M | $171.31M | $173.27M |
| QoQ Change | — | +43.9% | +1.9% | -0.8% | +13.8% | -13.7% | -57.3% | -9.6% | +40.6% | +1.1% | +38.2% | +39.0% | -35.8% | +28.6% | -18.3% | -24.5% | -21.7% | +17.1% | +32.4% | +1.1% |
| YoY Change | — | — | — | — | +65.4% | -0.7% | -58.4% | -62.1% | -53.1% | -45.1% | +77.6% | +173.0% | +24.7% | +58.6% | -6.3% | -49.1% | -37.9% | -43.5% | -8.4% | +22.8% |
Range$101.53M – $304.45M
CAGR-1.3%
Avg YoY Growth+3.6%
Median YoY Growth-7.3%
Current Streak3 quarters growth
Total investments at Other Companies
Frequently Asked Questions
- What is Royalty Pharma's total investments?
- Royalty Pharma (RPRX) reported total investments of $173.27M in Q1 2026.
- How has Royalty Pharma's total investments changed year-over-year?
- Royalty Pharma's total investments increased by 22.8% year-over-year, from $141.08M to $173.27M.
- What is the long-term trend for Royalty Pharma's total investments?
- Over 5 years (2020 to 2025), Royalty Pharma's total investments has grown at a -10.5% compound annual growth rate (CAGR), from $298.69M to $171.31M.
- What does total investments mean?
- The total value of all investment assets held by the bank.